SCHEMBL4063131

SCHEMBL4063131

Cn1c(=O)c2[nH]c(-c3ccc(S(=O)(=O)N4CCC(Cc5ccccc5)CC4)cc3)cc2n(C)c1=O

nearest known ligand 0.75

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 14/20 0.75
ADORA1 P30542 7/20 0.75
ADORA3 P0DMS8 6/20 0.75
ALDH1A1 P00352 1/20 0.59
HSD17B10 Q99714 1/20 0.59
ADORA2A P29274 1/20 0.56
SMN1; SMN2 Q16637 2/20 0.53
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
GAA P10253 1/20 0.51
TSHR P16473 1/20 0.51
HTT P42858 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4057447 0.86 ADORA2B (1.00) ADORA2BADORA1ADORA3ADORA2AKMT2A
SCHEMBL4054171 0.83 ADORA2B (0.93) ADORA2BADORA1ADORA3ADORA2AKMT2A
SCHEMBL4058517 0.83 ADORA2B (1.00) ADORA2BADORA1ADORA3ADORA2A
SCHEMBL4059808 0.80 ADORA2B (0.75) ADORA2BADORA1ADORA3ADORA2A
SCHEMBL4059841 0.80 ADORA2B (0.73) ADORA2BADORA1ADORA3ADORA2A
SCHEMBL4055040 0.79 ADORA2B (0.73) ADORA2BADORA1ADORA3ADORA2AKMT2A
SCHEMBL4056571 0.79 ADORA2B (1.00) ADORA2BADORA1ADORA3ALDH1A1ADORA2A
SCHEMBL4060656 0.79 ADORA2B (0.85) ADORA2BADORA1ADORA3ALDH1A1ADORA2A
SCHEMBL4055036 0.79 ADORA2B (0.73) ADORA2BADORA1ADORA3ADORA2AKMT2A
SCHEMBL4715957 0.78 ADORA2B (0.78) ADORA2BADORA1ADORA3ALDH1A1ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7504398-B2 potent and selective antagonists of adenosine receptors; Parkinson's disease, asthma, allergies, inflammation, atherosclerosis, hypertension, gastrointestinal disorders, cell proliferation and autoimmune diseases; sulfonamidation LABORATORIOS ALMIRALL S.A. (ES) 2009-03-17 US disclosed
EP-1492793-B1 NEW-4-(PYRROLOPYRIMIDIN-6-YL)BENZENESULPHONAMIDE DERIVATIVES ALMIRALL LAB (ES) 2008-01-16 EP disclosed